Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression

By Fekkes D.   Timmerman L.   Pepplinkhuizen L.  

European Neuropsychopharmacology, Vol. 7, Iss. 3, 1997-08 ,pp. : 235-239

Elsevier

Access to resources Recommend Favorite

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

By Sasson Y.   Iancu I.   Fux M.   Taub M.   Dannon P.N.   Zohar J.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

Panic disorder and the serotonin system

By Westenberg H.G.M.   den Boer J.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 183-184

Elsevier

Access to resources Recommend Favorite

5-HT 1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

By Broocks A.   Meyer T.   Opitz M.   Bartmann U.   Hillmer-Vogel U.   George A.   Pekrun G.   Wedekind D.   Ruther E.   Bandelow B.  

European Neuropsychopharmacology, Vol. 13, Iss. 3, 2003-05 ,pp. : 153-164

Elsevier

Access to resources Recommend Favorite

Effect of Dissociative Experiences on Drug Treatment of Panic Disorder

By Gulsun Murat  

Clinical Drug Investigation, Vol. 27, Iss. 8, 2007-01 ,pp. : 583-590

Adis International

Access to resources Recommend Favorite